PLD1 and breast carcinoma: When treated with isoform-specific PLD inhibitors, the viability of MDA-MB-231 breast cancer cells grown in the regular culture medium that contained high glucose (25 mM) was not significantly altered by either the PLD1 inhibitor (PLD1i) or PLD2 inhibitor (PLD2i) (Figure 1a).